• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于能量的皮肤科手术围手术期皮肤护理建议。

Recommendations on Periprocedural Skincare for Energy-Based Dermatologic Procedures.

作者信息

Goodman Greg, Yip Leona, McDonald Cara, Lin Frank, Liu Wenyuan, Sullivan John

出版信息

Aesthet Surg J Open Forum. 2025 May 9;7:ojaf039. doi: 10.1093/asjof/ojaf039. eCollection 2025.

DOI:10.1093/asjof/ojaf039
PMID:40575009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12198435/
Abstract

The use of energy-based device (EBD) aesthetic skin treatments is increasing in popularity. Implementation of periprocedural skincare may improve treatment-related outcomes, reduce recovery time, and reduce the frequency and severity of potential side effects. This review presents treatment recommendations to assist clinicians in optimizing integrated skincare to enhance EBD treatment outcomes. A panel of Australian 6 physicians (5 dermatologists, 1 plastic surgeon) developed 4 generalized EBD periprocedural skincare recommendations. These recommendations were divided based on 4 levels of skin barrier disruption caused by EBD treatment: none (or minimal), mild, moderate, and severe barrier disruption. The greater the disruption caused to the skin barrier, the greater care needed in choosing appropriate skincare products with suitable actives. Preprocedural skincare incorporating moisturizers, broad-spectrum sun-protection factor 50+ sunscreen, antioxidants, and niacinamide should be implemented at least 2 weeks before treatment to enhance skin barrier function and hydration. Postprocedure recommendations are made for the use of appropriate skincare actives that promote barrier repair and avoid further irritation. Prescription actives should be avoided for an appropriate period following EBD procedures; this period is dependent on the EBD treatment type and degree of skin barrier disruption it can cause. The algorithms provided here are aimed to assist clinicians in optimizing integrated skincare recommendations to enhance EBD treatment outcomes, promote healing, and reduce the likelihood of adverse events. Skincare recommendations made to patients should be based on the condition of the patient's skin, as well as the magnitude of skin barrier disruption caused by the EBD procedure.

摘要

基于能量的设备(EBD)用于美容皮肤治疗的情况日益普遍。围手术期皮肤护理的实施可能会改善与治疗相关的结果,减少恢复时间,并降低潜在副作用的发生频率和严重程度。本综述提出了治疗建议,以帮助临床医生优化综合皮肤护理,提高EBD治疗效果。一个由6名澳大利亚医生(5名皮肤科医生、1名整形外科医生)组成的小组制定了4条通用的EBD围手术期皮肤护理建议。这些建议根据EBD治疗对皮肤屏障造成的4种破坏程度进行划分:无(或最小)、轻度、中度和重度屏障破坏。对皮肤屏障造成的破坏越大,在选择含有合适活性成分的合适护肤品时就需要越谨慎。术前皮肤护理应在治疗前至少2周实施,包括使用保湿剂、广谱防晒系数50+的防晒霜、抗氧化剂和烟酰胺,以增强皮肤屏障功能和保湿。术后建议使用促进屏障修复且避免进一步刺激的合适皮肤护理活性成分。EBD手术后应在适当的时间段内避免使用处方活性成分;这个时间段取决于EBD治疗类型及其可能导致的皮肤屏障破坏程度。此处提供的算法旨在帮助临床医生优化综合皮肤护理建议,以提高EBD治疗效果、促进愈合并降低不良事件的发生可能性。向患者提供的皮肤护理建议应基于患者的皮肤状况以及EBD手术对皮肤屏障造成的破坏程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4fb94d3ca2b3/ojaf039f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/dad9cc062808/ojaf039f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4283e34e6aed/ojaf039f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4f8070ce9d2b/ojaf039f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4fb94d3ca2b3/ojaf039f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/dad9cc062808/ojaf039f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4283e34e6aed/ojaf039f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4f8070ce9d2b/ojaf039f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3854/12198435/4fb94d3ca2b3/ojaf039f4.jpg

相似文献

1
Recommendations on Periprocedural Skincare for Energy-Based Dermatologic Procedures.基于能量的皮肤科手术围手术期皮肤护理建议。
Aesthet Surg J Open Forum. 2025 May 9;7:ojaf039. doi: 10.1093/asjof/ojaf039. eCollection 2025.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].[寻常型银屑病的窄谱中波紫外线治疗:法国光皮肤病学会的实用指南与建议]
Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29.
4
Interventions for preventing occupational irritant hand dermatitis.预防职业性刺激性手部皮炎的干预措施。
Cochrane Database Syst Rev. 2018 Apr 30;4(4):CD004414. doi: 10.1002/14651858.CD004414.pub3.
5
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
6
Sun protection for preventing basal cell and squamous cell skin cancers.预防基底细胞癌和鳞状细胞皮肤癌的防晒措施。
Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews.预防手术部位感染的术中干预措施:Cochrane系统评价概述
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD012653. doi: 10.1002/14651858.CD012653.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.依那西普和英夫利昔单抗治疗银屑病关节炎:系统评价与经济学评估
Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. doi: 10.3310/hta10310.

本文引用的文献

1
A Practical Algorithm for Integrating Skincare to Improve Patient Outcomes and Satisfaction With Energy-Based Dermatologic Procedures.一种实用的皮肤护理整合算法,可改善患者对基于能量的皮肤科手术的治疗效果和满意度。
J Drugs Dermatol. 2024 May 1;23(5):353-359. doi: 10.36849/JDD.8092.
2
Revitalizing the skin: Exploring the role of barrier repair moisturizers.焕发肌肤活力:探索屏障修复保湿霜的作用。
J Cosmet Dermatol. 2024 May;23(5):1533-1540. doi: 10.1111/jocd.16171. Epub 2024 Jan 12.
3
Guide to tinted sunscreens in skin of color.有色防晒霜在有色皮肤中的应用指南。
Int J Dermatol. 2024 Mar;63(3):272-276. doi: 10.1111/ijd.16954. Epub 2023 Dec 10.
4
How to Promote Skin Repair? In-Depth Look at Pharmaceutical and Cosmetic Strategies.如何促进皮肤修复?深入探讨药物和化妆品策略。
Pharmaceuticals (Basel). 2023 Apr 11;16(4):573. doi: 10.3390/ph16040573.
5
Supplement Individual Article: Algorithm for Pre-/Post-Procedure Measures in Racial/Ethnic Populations Treated With Facial Lasers, Nonenergy Devices, or Injectables.补充文章:面部激光、非能量设备或注射治疗的种族/族裔人群的术前/术后措施算法。
J Drugs Dermatol. 2022 Oct 1;21(10):SF3509903-SF35099011.
6
Association of Early Clinical Response to Laser Rejuvenation of Photoaged Skin with Increased Lipid Metabolism and Restoration of Skin Barrier Function.早期临床应答与激光焕肤治疗光老化皮肤的关系:改善皮肤脂质代谢和修复皮肤屏障功能。
J Invest Dermatol. 2023 Mar;143(3):374-385.e7. doi: 10.1016/j.jid.2022.07.024. Epub 2022 Aug 31.
7
Contact sensitization to essential oils: IVDK data of the years 2010-2019.接触精油过敏:2010-2019 年 IVDK 数据。
Contact Dermatitis. 2022 Jul;87(1):71-80. doi: 10.1111/cod.14126. Epub 2022 Apr 25.
8
Safety and efficacy of combined essential oils for the skin barrier properties: In vitro, ex vivo and clinical studies.联合精油对皮肤屏障特性的安全性和功效:体外、离体和临床研究。
Int J Cosmet Sci. 2022 Feb;44(1):118-130. doi: 10.1111/ics.12761. Epub 2022 Feb 10.
9
Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.评估氨甲环酸、烟酰胺和曲酸激光辅助给药治疗黄褐斑的耐受性和疗效:一项单中心、前瞻性、半脸试验。
Dermatol Ther. 2022 Mar;35(3):e15287. doi: 10.1111/dth.15287. Epub 2022 Jan 4.
10
Review of Post-laser-resurfacing Topical Agents for Improved Healing and Cosmesis.用于改善愈合和美容效果的激光换肤后局部用药综述。
J Clin Aesthet Dermatol. 2021 Aug;14(8):24-32. Epub 2021 Aug 1.